Recent studies have shown that levels of mTOR significantly restrains human and murine adipogenesis and activation of energy metabolism, as previously determined in human NAFLD, using different adipose tissues, while their downregulation obesity and lipotoxicity [44]. This evidence concerns the gene MTOR and metabolic dysfunction-associated steatotic liver disease.